Prodrugs for improving tumor targetability and efficiency.
Prodrugs for improving tumor targetability and efficiency.
复制标题
DOI:
10.1016/j.addr.2011.02.002
复制
发表时间:
2011-07-18
影响因子:
16.1
通讯作者:
Cheng, Kun
中科院分区:
文献类型:
--
作者:
Mahato, Rubi;Tai, Wanyi;Cheng, Kun
As the mainstay in the treatment of various cancers for several decades, chemotherapy is successful but still faces challenges including non-selectivity and high toxicity. Improving the selectivity is therefore a critical step to improve the therapeutic efficacy of chemotherapy. Prodrug is one of the most promising approaches to increase the selectivity and efficacy of a chemotherapy drug. The classical prodrug approach is to improve the pharmaceutical properties (solubility, stability, permeability, irritation, distribution, etc.) via a simple chemical modification. This review will focus on various targeted prodrug designs that have been developed to increase the selectivity of chemotherapy drugs. Various tumor-targeting ligands, transporter-associated ligands, and polymers can be incorporated in a prodrug to enhance the tumor uptake. Prodrugs can also be activated by enzymes that are specifically expressed at a higher level in tumors, leading to a selective anti-tumor effect. This can be achieved by conjugating the enzyme to a tumor-specific antibody, or delivering a vector expressing the enzyme into tumor cells.
登录
查看更多内容
DOI:
10.1124/jpet.105.100347
发表时间:
2006-05-01
影响因子:
3.5
作者:
Cheng, K;Ye, ZY;Mahato, RI
通讯作者:
Mahato, RI
影响因子:
11.5
作者:
Braybrooke, JP;Slade, A;Harris, AL
通讯作者:
Harris, AL
影响因子:
45.3
作者:
Chévez-Barrios, P;Chintagumpala, M;Hurwitz, RL
通讯作者:
Hurwitz, RL
DOI:
10.1073/pnas.0504274102
发表时间:
2005-09-06
影响因子:
11.1
作者:
Dharap, SS;Wang, Y;Minko, T
通讯作者:
Minko, T
影响因子:
14.9
作者:
Chu, Ted C.;Twu, Karen Y.;Ellington, Andrew D.;Levy, Matthew
通讯作者:
Levy, Matthew